IDEXX Laboratories, Inc. (IDXX)
Last Price$419.5(0.7%)
Market Cap$34.5B
IDXX Rating
IDXX Quality rating performance
IDXX Intrinsic Value
Key Highlights:
As of Mar 18, 2025 IDXX Relative Value is $295.1, which is overvalued by 29.7%, compared to current share price of $419.5.
As of Mar 18, 2025 IDXX DCF Value is $150.3, which is overvalued by 64.2%, compared to current share price of $419.5.
IDXX Share Price History
1W (1.6%)
1M (6.6%)
6M (18.0%)
YTD (23.4%)
1Y (20.8%)
3Y (22.7%)
5Y 104.5%
10Y 453.3%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
IDXX Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$34.5B
$34.3B
$3,897.5M
$798.1M
Shares Outstanding
82M
Employees
11K
Growth (CAGR)
10.1%
15.4%
16.75%
21.3%
11.01%
Profitability
61.1%
29.0%
22.8%
23.8%
20.5%
89.9%
Intrinsic Value
$223.2 (46.8% overvalued)
$151.0
$295.3
$131.4
$166.2
24.5%
Return on Capital
Financial Health
($120.5M)
(0.2x)
36.2x
10.5%
Dividends
Earnings
Aug 04, 2025
BEAT by 2.0%
BEAT by 8.8%
(8.1%)
10 Beat & null Miss
IDXX Stock Financials
IDXX Income Statement Metrics
Annual
Quarterly
LTM
IDXX Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$929.0M +2.5% YoY
Capital Expenditure (CAPEX)
($130.9M) -2.0% YoY
Free Cash Flow (FCF)
$798.1M +3.3% YoY
IDXX Income Statement Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
$3,897.5M 6.5% YoY
Cost of revenue
$1,518.6M 3.2% YoY
Pre-tax income
$1,109.8M 4.6% YoY
28.5% margin
IDXX Balance Sheet Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$3,293.4M
Current assets ($1,399.9M, 42.5% of total)
$288.3M (8.8%)
$473.6M (14.4%)
Other current assets
$638.1M (19.4%)
Non-current assets ($1,893.5M, 57.5% of total)
$57.7M (1.8%)
$829.3M (25.2%)
$111.7M (3.4%)
Other non-current assets
$894.9M (27.2%)
Financial position
($22.6M)
Cash & Short-term
Investments
Total Debt
IDXX Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
IDXX Earnings Surprises
Crunching data... Almost there!
IDXX Dividends
IDXX Dividend Yield
Crunching data... Almost there!
IDXX Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with IDXX
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$34.5B | 7.1 | $223.2 46.8% overvalued | (20.8%) | $3,897.5M | $798.1M | 6.5% | 20.5% | 61.1% | 42.1% | 10.5% | |
$197.5B | 6.4 | $652.0 25.0% undervalued | (9.9%) | $42.9B | $7,267.0M | 0.1% | 16.9% | 41.5% | 7.9% | 63.0% | |
$153.8B | 6.0 | $162.8 23.5% overvalued | (15.0%) | $23.9B | $5,296.0M | (0.1%) | 22.2% | 59.5% | 5.9% | 32.3% | |
$34.7B | 7.2 | $98.0 20.4% overvalued | (15.2%) | $6,533.0M | $1,409.0M | (3.0%) | 21.6% | 54.0% | 14.7% | 55.8% | |
$33.7B | 6.1 | $300.9 59.6% undervalued | (25.7%) | $15.4B | $2,114.0M | 2.5% | 13.7% | 31.4% | 9.0% | 24.6% | |
$25.9B | 6.9 | $862.7 30.6% overvalued | (4.9%) | $3,872.4M | $864.4M | 2.2% | 22.3% | 59.1% | 40.7% | (1,587.1%) | |
$22.4B | 6.7 | $239.8 37.2% overvalued | 10.0% | $2,958.4M | $619.6M | 0.1% | 20.9% | 58.2% | 19.7% | 93.1% | |
$19.1B | 6.0 | $347.6 101.5% undervalued | 37.4% | $9,872.0M | $909.0M | 6.7% | 9.2% | 32.4% | 7.9% | 100.4% | |
$19.1B | 6.0 | $86.6 40.8% overvalued | 62.3% | $1,696.9M | $69.2M | 56.7% | 4.1% | 60.3% | (39.5%) | 15.7% | |
$15.1B | 6.4 | $330.4 77.6% undervalued | (44.1%) | $8,281.7M | $1,116.7M | 2.0% | 13.5% | 25.8% | 6.8% | 37.4% | |
$13.5B | 6.6 | $129.3 14.7% undervalued | 8.5% | $2,755.0M | $541.7M | 0.2% | 19.7% | 52.5% | 3.1% | 43.1% |
FAQ
What is IDEXX Laboratories, Inc. (IDXX) stock rating?
As of today, IDEXX Laboratories, Inc. has a stock rating of 7 (out of 10), which is considered Great.
is IDEXX Laboratories, Inc. (IDXX) a good stock to buy?
As of today, IDEXX Laboratories, Inc. has a Great stock rating, which is 46.8% overvalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 0.5%.